Retraction Note: J Exp Clin Cancer Res 38, 97 (2019)
https://doi.org/10.1186/s13046-019-1023-4
The Editor-in-Chief has retracted this article. Concerns have been raised regarding a number of figures, specifically:
Figure 9A: the panels for 0 h/siRNA-LHX2 and 0 h/miR-506 inhibitor + siRNA-LHX2 appear to partially overlap
Figure 9B: the panels for 0 h/Blank and 0 h/NC appear to partially overlap
Figure 9B: the panels for 0 h/miR-506 mimic and 0 h/miR-506 inhibitor appear to be identical
Additionally, the background of the western blots in Figures 2B, 4A, 5B, 5D, 5H and 5 J appear to look unexpectedly clean. Author Zhang-Suo Liu has also stated that he was unaware of the submission and publication of this article. The Editor-in-Chief therefore no longer has confidence in the reliability of the data reported in the article.
The authors have not responded to correspondence regarding this retraction notice.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Tian-Song Liang and Ying-Juan Zheng contributed equally to this work.
Contributor Information
Dao-Ke Yang, Email: yangdaokedr@163.com.
Zhang-Suo Liu, Email: liu_zhangsuo@yeah.net.